10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,934,258 | +24.1% | 555,982 | +68.0% | 0.11% | +29.9% |
| Q2 2023 | $18,485,274 | +1.4% | 331,040 | +1.3% | 0.09% | -4.4% |
| Q1 2023 | $18,227,039 | -6.0% | 326,708 | -38.6% | 0.09% | -15.7% |
| Q4 2022 | $19,393,441 | -10.3% | 532,202 | -29.9% | 0.11% | -7.7% |
| Q3 2022 | $21,626,000 | -39.0% | 759,331 | -3.0% | 0.12% | -36.1% |
| Q2 2022 | $35,434,000 | +27.8% | 783,062 | +114.9% | 0.18% | +16.6% |
| Q1 2022 | $27,716,000 | +1326.5% | 364,344 | +2693.2% | 0.16% | +1327.3% |
| Q4 2021 | $1,943,000 | +59.7% | 13,044 | +56.1% | 0.01% | +37.5% |
| Q3 2021 | $1,217,000 | -77.7% | 8,357 | -70.0% | 0.01% | -78.9% |
| Q2 2021 | $5,463,000 | +2244.6% | 27,896 | +2067.5% | 0.04% | +1800.0% |
| Q1 2021 | $233,000 | -93.1% | 1,287 | -94.6% | 0.00% | -92.9% |
| Q4 2020 | $3,371,000 | -67.8% | 23,810 | -71.6% | 0.03% | -67.8% |
| Q3 2020 | $10,460,000 | +428.0% | 83,898 | +278.3% | 0.09% | +278.3% |
| Q2 2020 | $1,981,000 | – | 22,178 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |